1. Home
  2. NUVL vs PL Comparison

NUVL vs PL Comparison

Compare NUVL & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$100.82

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$22.42

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
PL
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
PL
Price
$100.82
$22.42
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$135.00
$17.10
AVG Volume (30 Days)
497.6K
13.4M
Earning Date
02-27-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$282,459,000.00
Revenue This Year
N/A
$26.28
Revenue Next Year
N/A
$26.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.89
52 Week Low
$55.54
$2.79
52 Week High
$113.02
$30.90

Technical Indicators

Market Signals
Indicator
NUVL
PL
Relative Strength Index (RSI) 49.64 44.39
Support Level $98.65 $19.98
Resistance Level $106.57 $24.10
Average True Range (ATR) 4.46 2.05
MACD -0.29 -0.70
Stochastic Oscillator 47.36 15.02

Price Performance

Historical Comparison
NUVL
PL

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

Share on Social Networks: